Datopotamab Deruxtecan-dlnk
Generic Name: datopotamab deruxtecan-dlnk
Manufactured by DAIICHI SANKYO INC. Dosage form: INJECTABLE. Route: INJECTION. Active ingredients: DATOPOTAMAB DERUXTECAN-DLNK (100MG). Application: BLA761464.
Overview
Manufactured by DAIICHI SANKYO INC. Dosage form: INJECTABLE. Route: INJECTION. Active ingredients: DATOPOTAMAB DERUXTECAN-DLNK (100MG). Application: BLA761464.
Dosage
Available as injectable for injection use.
Related Medications
Tremelimumab
tremelimumab
CTLA-4-directed Blocking Antibody [EPC]
11 DESCRIPTION Tremelimumab-actl, a cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4) blocking human IgG2 monoclonal antibody, is produced by recombinant DNA technology in NS0 cell suspension culture and has a molecular weight of 149 kDa. IMJUDO (tremelimumab-actl) injection is a sterile, preservative-free, clear to slightly opalescent, colorless to slightly yellow solution, in a single-dose vial for intravenous infusion after dilution.
Bismuth
bismuth
Bismuth [EPC]
Purpose Upset stomach reliever and antidiarrheal
Tovorafenib
tovorafenib
Kinase Inhibitor [EPC]
11 DESCRIPTION OJEMDA contains tovorafenib, a kinase inhibitor. Tovorafenib has the molecular formula C 17 H 12 Cl 2 F 3 N 7 O 2 S and a molecular weight of 506.29. The chemical name for tovorafenib is 6-amino-5-chloro-N-[(1R)-1-[5-[[[5-chloro-4-(trifluoromethyl)-2-pyridinyl]amino]carbonyl]-2-thiazolyl]ethyl]-4-pyrimidinecarboxamide. Tovorafenib has the following chemical structure: It is a white to off-white powder.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.